Altria Group (MO)
(Delayed Data from NYSE)
$53.77 USD
+0.41 (0.77%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $53.82 +0.05 (0.09%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$53.77 USD
+0.41 (0.77%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $53.82 +0.05 (0.09%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Zacks News
Altria Group has been evolving with the changing industry dynamics. Given the rising health consciousness and stern government regulations to discourage smoking, this tobacco behemoth has been moving beyond traditional cigarettes and expanding in the smokeless category. We note that revenues from the oral product category have been steadily rising on the back of growing popularity for reduced risk products. In this respect, Altria is gaining from the sale of IQOS in United States, through its licensing deal with Phillip Morris. Further, Altria’s investment in Cronos Group highlights its focus on exploring the cannabis market.
Altria (MO) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
In the most recent trading session, Altria (MO) closed at $53.77, indicating a +0.77% shift from the previous trading day.
Altria (MO) Up 6.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Altria (MO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Altria Rallies 15% in 3 Months: Should You Buy, Hold or Sell MO Stock?
by Vrishali Bagree
Altria's push into smoke-free products presents promising growth opportunities, but the ongoing decline in its cigarette business poses challenges for MO stock.
Should VanEck Morningstar Wide Moat ETF (MOAT) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for MOAT
Zacks Investment Ideas feature highlights: Cardinal Health, Taiwan Semiconductor and Altria
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Cardinal Health, Taiwan Semiconductor and Altria.
3 Consistent Dividend Growers to Buy for Passive Income: TSM, MO, CAH
by Derek Lewis
For those seeking companies with a consistent history of steady payouts, all three of these stocks fit the criteria. Who doesn't like payday?
Top Stock Reports for Toyota Motor, IBM & Stryker
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corporation (TM), International Business Machines Corporation (IBM) and Stryker Corporation (SYK), as well a micro-cap stock Fossil Group, Inc. (FOSL).
Altria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Should iShares Select Dividend ETF (DVY) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for DVY
Is iShares Select Dividend ETF (DVY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for DVY
Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Altria (MO) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Is Invesco High Yield Equity Dividend Achievers ETF (PEY) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for PEY
Company News for Aug 1, 2024
by Zacks Equity Research
Companies in The News Are: AMD, ANET, MA, MO
Altria's (MO) Q2 Earnings Lag Estimates, Cigarette Volumes Drop
by Zacks Equity Research
Altria's (MO) second-quarter 2024 results reflect strong pricing, while cigarette shipment volumes remain soft. Management narrows the adjusted EPS view for 2024.
Altria (MO) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of -2.96% and 2.77%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Is Franklin U.S. Low Volatility High Dividend Index ETF (LVHD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for LVHD
Altria's (MO) Q2 Earnings Coming Up: Buy, Sell or Hold Steady?
by Vrishali Bagree
Altria Group's (MO) second-quarter earnings are likely to reflect gains from the company's pricing power and smoke-free product strength amid soft cigarette volumes.
Is SPDR S&P Global Dividend ETF (WDIV) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for WDIV
Altria (MO) Hits 52-Week High: Time to Cash In or Hold Steady?
by Vrishali Bagree
Altria's (MO) strategic moves into smoke-free products offer growth potential, though the declining cigarette business raises concerns.
Why the Market Dipped But Altria (MO) Gained Today
by Zacks Equity Research
Altria (MO) concluded the recent trading session at $49.80, signifying a +0.77% move from its prior day's close.
Altria (MO) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Altria (MO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors Heavily Search Altria Group, Inc. (MO): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Philip Morris (PM) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of 2.58% and 3.38%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Why the Market Dipped But Altria (MO) Gained Today
by Zacks Equity Research
Altria (MO) reachead $49.45 at the closing of the latest trading day, reflecting a +0.24% change compared to its last close.
Is Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SPHD